Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Jul 21, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹44.141-0.64% 1 day change | 24.93% p.a. | ₹2,961 Cr |
Expense ratio | 0.62% as on May 31, 2025 |
Exit load | 0.5% Exit load of 0.50% if redeemed within 1 month.! |
AUM (Fund size) | ₹2,961 Cr |
Lock-in Period | Nil |
Age | 6 yrs 8 m since Nov 12, 2018 |
Benchmark | BSE Healthcare TRI |
Min. investment | SIP: ₹500 & Lumpsum: ₹500 |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Period | This fund | Category average |
---|---|---|
1 Month | 4.09% | 3.63% |
3 Months | 6.33% | 6.89% |
6 Months | 0.19% | 5.47% |
1 Year | 14.3% | 17.31% |
2 Years | 28.22% | 29.28% |
3 Years | 27.12% | 26.32% |
4 Years | 17.13% | 15.93% |
5 Years | 24.42% | 23.32% |
Large Cap 25.75%
Mid Cap 19.58%
Small Cap 54.27%
Other Cap 0%
Healthcare 97.52%
Insurance 1.53%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Foreign - Equity 12.71%
Reverse Repo 0.6%
Foreign Mutual Funds 0.55%
Others 0.6%
Global X Genomics & Biotechnology ETF 0.55%
Fund name | ETM Rank | AUM | Fund age | Expense ratio |
---|---|---|---|---|
DSP Healthcare Fund | N.A. | 2,961 Cr | 6 yrs 8 m | 0.62% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 5,295 Cr | 7 yrs 1 m | 1.06% |
SBI Healthcare Opportunities Fund | N.A. | 3,671 Cr | 12 yrs 6 m | 0.9% |
Tata India Pharma & HealthCare Fund | N.A. | 1,232 Cr | 9 yrs 7 m | 0.63% |
Mirae Asset Healthcare Fund | N.A. | 2,691 Cr | 7 yrs 1 m | 0.5% |
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
DSP Healthcare Fund | 4.09% | 0.19% | 14.3% | 27.12% | 24.42% | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 4.09% | 7.52% | 21.23% | 30.15% | 25.59% | 16.02% |
SBI Healthcare Opportunities Fund | 3.05% | 6.19% | 21.0% | 29.45% | 25.4% | 13.03% |
Tata India Pharma & HealthCare Fund | 3.06% | 3.68% | 13.15% | 25.54% | 23.75% | 13.51% |
Mirae Asset Healthcare Fund | 4.78% | 7.03% | 16.41% | 25.1% | 24.13% | 15.97% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
DSP Healthcare Fund | 14.68 | 0.85 | 1.35 | 2.22 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.37 | 0.94 | 1.44 | 2.04 |
SBI Healthcare Opportunities Fund | 13.71 | 0.84 | 1.58 | 2.27 |
Tata India Pharma & HealthCare Fund | 15.95 | 0.99 | 1.2 | 1.83 |
Mirae Asset Healthcare Fund | 16.24 | 1.0 | 1.11 | 1.76 |
Alpha | 3.1 vs. 6.7 Underperformed at beating benchmark |
Sharpe | 1.35 vs. 4.61 Poor risk-adjusted returns |
Beta | 0.85 vs. 0.79 More sensitive to market's ups & downs |
Standard deviation | 14.68 vs. 9.0 More volatile performance |
Fund AUM | 2,961 Cr as on May 31, 2025 |
Scheme document | View Scheme Document |
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
No. of schemes | 50 view all schemes |
Total AUM | 1,98,256 Cr as on Jun 30, 2025 |
Address | NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai, 400069 |
Phone | 1800-208-4499 / 1800-200-4499 |
Fund name | ETM Rank | AUM | 1Y | 5Y |
---|---|---|---|---|
DSP India T.I.G.E.R. Fund | N.A. | 5,319 Cr | -2.63% | 34.78% |
DSP Small Cap Fund | N.A. | 16,305 Cr | 8.65% | 32.97% |
DSP Natural Resources and New Energy Fund | N.A. | 1,292 Cr | -1.56% | 27.73% |
DSP ELSS Tax Saver Fund | N.A. | 16,974 Cr | 4.58% | 25.42% |
DSP Large & Mid Cap Fund | N.A. | 15,013 Cr | 3.33% | 24.73% |
The current Net Asset Value (NAV) of the DSP Healthcare Fund - Direct Growth plan is approximately ₹44.141 as of Jul 21, 2025.
The DSP Healthcare Fund is a 6 yrs 8 m old fund and has delivered average annual returns of 24.93% since inception.
1-Year | 3-Year | 5-Year | Since Inception |
---|---|---|---|
14.3% | 27.12% | 24.42% | 24.93% |
The DSP Healthcare Fund - Direct Growth has an expense ratio of 0.62%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.
The DSP Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 2,961 Cr as on May 31, 2025.
The DSP Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Cipla Ltd. | 8.86% |
Cohance Lifesciences Ltd. | 8.81% |
Sun Pharmaceutical Industries Ltd. | 8.7% |
Ipca Laboratories Ltd. | 8.16% |
Gland Pharma Ltd. | 4.94% |
Alembic Pharmaceuticals Ltd. | 4.91% |
Globus Medical Inc | 4.59% |
Laurus Labs Ltd. | 4.57% |
Apollo Hospitals Enterprise Ltd. | 4.53% |
Sai Life Sciences Ltd. | 4.08% |
The DSP Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 97.52% |
Insurance | 1.53% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. It is just a matter of a few minutes. Here's how:
For the Desktop Version:
For the Mobile Version:
All set! Your investment in DSP Healthcare Fund is complete.
Redeeming your investments in DSP Healthcare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in DSP Healthcare Fund from anywhere else, you can go to the fund house website and put a request through it.